MPAL

Clinical trials for MPAL explained in plain language.

Never miss a new study

Get alerted when new MPAL trials appear

Sign up with your email to follow new studies for MPAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for rare leukemia: combo therapy targets tough cases

Disease control Not yet recruiting

This study is for adults with a rare leukemia that is hard to treat. It combines targeted immune drugs with chemotherapy to see if it can help patients live longer and achieve remission. About 50 people will take part across multiple hospitals in China.

Matched conditions: MPAL

Phase: NA • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control

Last updated May 17, 2026 04:14 UTC

MPAL

Get alerted when new MPAL trials appear

New hope for rare leukemia: combo therapy targets tough cases